Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP819041.RAfgUu-6tE_hlrx45ew1U2YjYPMwkjG4m2Z2uL0fm8MTc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP819041.RAfgUu-6tE_hlrx45ew1U2YjYPMwkjG4m2Z2uL0fm8MTc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP819041.RAfgUu-6tE_hlrx45ew1U2YjYPMwkjG4m2Z2uL0fm8MTc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP819041.RAfgUu-6tE_hlrx45ew1U2YjYPMwkjG4m2Z2uL0fm8MTc130_provenance.
- NP819041.RAfgUu-6tE_hlrx45ew1U2YjYPMwkjG4m2Z2uL0fm8MTc130_assertion description "[Our data suggest that transactivation of CDCA5 and its phosphorylation at Ser209 by ERK play an important role in lung cancer proliferation, and that the selective suppression of the ERK-CDCA5 pathway could be a promising strategy for cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP819041.RAfgUu-6tE_hlrx45ew1U2YjYPMwkjG4m2Z2uL0fm8MTc130_provenance.
- NP819041.RAfgUu-6tE_hlrx45ew1U2YjYPMwkjG4m2Z2uL0fm8MTc130_assertion evidence source_evidence_literature NP819041.RAfgUu-6tE_hlrx45ew1U2YjYPMwkjG4m2Z2uL0fm8MTc130_provenance.
- NP819041.RAfgUu-6tE_hlrx45ew1U2YjYPMwkjG4m2Z2uL0fm8MTc130_assertion SIO_000772 20551060 NP819041.RAfgUu-6tE_hlrx45ew1U2YjYPMwkjG4m2Z2uL0fm8MTc130_provenance.
- NP819041.RAfgUu-6tE_hlrx45ew1U2YjYPMwkjG4m2Z2uL0fm8MTc130_assertion wasDerivedFrom befree-2016 NP819041.RAfgUu-6tE_hlrx45ew1U2YjYPMwkjG4m2Z2uL0fm8MTc130_provenance.
- NP819041.RAfgUu-6tE_hlrx45ew1U2YjYPMwkjG4m2Z2uL0fm8MTc130_assertion wasGeneratedBy ECO_0000203 NP819041.RAfgUu-6tE_hlrx45ew1U2YjYPMwkjG4m2Z2uL0fm8MTc130_provenance.
- befree-2016 importedOn "2016-02-19" NP819041.RAfgUu-6tE_hlrx45ew1U2YjYPMwkjG4m2Z2uL0fm8MTc130_provenance.